Loading clinical trials...
Loading clinical trials...
This trial is conducted in Canada, Asia, Europe and USA. The aim of this clinical trial is to investigate the effect and safety of rFXIII on transfusion needs in patients undergoing heart surgery.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT06899971 · Cardiac Surgery Requiring Cardiopulmonary Bypass, Brain Injury, and more
NCT07009730 · Cardiac Surgery, Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT06882759 · Cardiac Surgery Requiring Cardiopulmonary Bypass
NCT00426803 · Acquired Bleeding Disorder, Intracerebral Haemorrhage
NCT01563445 · Acquired Bleeding Disorder, Intracerebral Haemorrhage
Novo Nordisk Investigational Site
Atlanta, Georgia
Novo Nordisk Investigational Site
Durham, North Carolina
Novo Nordisk Investigational Site
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions